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Abstract
Background: Clinical trials in the general practice setting are important for providing evidence on the effectiveness 
and safety of different agents under various conditions. In conducting these trials, the participation of physicians and 
patient recruitment are important issues. Various investigations in the literature have reported views and attitudes of 
physicians on various types of clinical trials. Nevertheless, there is still little information concerning physicians 
participating in a clinical trial and among them, those who could not recruit any patients (unsuccessful physician 
recruiters).
Methods: In 2003, we collaborated in a large-scale multicenter study of Japanese hypertensive patients (COPE Trial). In 
Tokushima University Hospital and 18 other medical institutions, we investigated the views and attitudes of 
unsuccessful physician recruiters in comparison with successful physician recruiters, using a questionnaire.
Results: The questionnaire was provided by mail to 47 physicians and 27 (57%) responded. The response rate was 79% 
for successful physician recruiters compared to 43% (P = 0.014) for unsuccessful physician recruiters. More successful 
physician recruiters (73%) than unsuccessful physician recruiters (42%) stated they had participated and enrolled 
patients in previous multicenter clinical trials. A significantly higher number of successful physician recruiters than 
unsuccessful physician recruiters (42%; P = 0.040) considered the presence of a support system with clinical research 
coordinators (CRC) as the reason for participation (80%). A large number of unsuccessful physician recruiters 
experienced difficulty in obtaining informed consent (67%), whereas a significantly smaller number of successful 
physician recruiters experienced such difficulty (20%; P = 0.014). The difficulties experienced by unsuccessful physician 
recruiters in the trial were as follows: inability to find possible participants (100%), difficulty in obtaining informed 
consent (58%), cumbersome procedures (58%), difficulty in long-term follow up (33%), and insufficient tools for 
explanation and obtaining informed consent (8%).
Conclusion: This survey showed that successful physician recruiters consider a support system with CRC of value, and 
that they are skillful in obtaining informed consent. These views and attitudes may have originated from past 
experience involving clinical trials. In this regard, we need to develop an infrastructure to enlighten physicians on this 
support system for the promotion of clinical trials.
Background
An increasing number of clinical trials are seen in the
general practice setting, aiming at providing evidence for
the effectiveness and safety of different agents under vari-
ous conditions. In conducting these trials, the participa-
tion of primary healthcare physicians in the community
(general practitioners; GPs) and patient recruitment are
important issues that need to be properly addressed. Var-
ious studies in the literature have reported factors affect-
ing physicians' participation [1,2] and patient recruitment
[3,4] in clinical trials, and infrastructure for clinical trials
may affect these important issues.
As for the Japanese infrastructure for clinical trials, the
concept of clinical research coordinators (CRC) has been
introduced in clinical trials leading to drug approval (reg-
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istration trials), since the introduction of the Good Clini-
cal Practice standard approved by the International
Conference on Harmonisation of Technical Require-
ments for Registration of Pharmaceuticals for Human
Use in 1997.On the other hand, the infrastructure for
other types of clinical trial remains unsatisfactory, mainly
because of financial reasons, and investigators still have
to do virtually everything from patient care to adminis-
trative work during the course of the study.
In 2003, we collaborated in a large-scale investigator-
initiated multicenter study of Japanese hypertensive
patients for the trial of a combination of antihypertensive
agents (COPE Trial) [5]. This study was not a registration
trial and it should be emphasized that CRC, by virtue of
their contract with the Coordinating Center of the trial,
supported investigators at various points, such as in
recruitment and follow up of participants. Here, we pres-
ent the results of investigations involving physicians who
participated in the above-mentioned clinical study, with
emphasis on characteristics of physicians who partici-
pated and could not recruit patients, and discuss regard-
ing the establishment of an infrastructure for assisting
physicians during participation in clinical trials.
Methods
The collaborating study was a large-scale investigator-ini-
tiated multicenter study of Japanese hypertensive patients
for the trial of a combination of antihypertensive agents
(COPE Trial) [5]. The trial was conducted with the coop-
eration of more than 100 centers and clinics in Japan and
involved 3,000 patients followed up for 3 years. The inclu-
sion criteria was as follows: 1. Outpatients who are
required a combination therapy with sitting systolic
blood pressure ≥ 140 mmHg or diastolic blood pressure ≥
90 mmHg; 2. Outpatients aged over 40 years and less than
85 years (inclusive), regardless of sex; 3. Previously
untreated patients or patients who are on other therapy,
which can be converted to 4 mg of benidipine; 4. Patients
who can be treated with benidipine, angiotensin receptor
blockers, β-blockers, and thiazide diuretics. Tokushima
University Hospital (17 physicians) and 18 medical insti-
tutions (17 community-affiliated physicians from 6 hos-
pitals and 13 physicians from 12 clinics) in Tokushima
Prefecture, Japan, participated in this trial. Eligible
patients were enrolled from May 2003 until November
2006, and 19 (40%) physicians eventually recruited
patients in the clinical trial.
A questionnaire designed specifically for this study was
composed of practical questions such as those regarding
experience in trial participation and patient enrollment in
the previous studies (Questions 1&2). This was followed
by questions where attitudes and views were examined on
a three-point scale (agree, neutral and disagree). The
questions were regarding reasons for participating as
investigators in the recent clinical trial (Question 3),
views of physicians on the recent clinical trial after partic-
ipation (Question 4), difficulties experienced by recruit-
ing-incapable physicians in patient enrollment in the
recent clinical trial (Question 5) and expectation regard-
ing the support system provided by CRC and satisfaction
from CRC participating in the recent clinical trial (Ques-
tion 6). The questionnaire was provided by mail to all
physicians participating in the clinical trial irrespective of
patient recruitment in May 2007 after the end of the
patient recruitment period, and was recovered separately
from Tokushima University Hospital and other medical
institutions in order to identify the category of the medi-
cal institutions to which the respondents belong.
We compared the views of physicians based on two cat-
egories: physicians who actually recruited patients in the
clinical trial (successful physician recruiters) and those
who could not (unsuccessful physician recruiters). Cate-
gorical variables were analyzed using the χ2 or Fisher's
exact test. P values < 0.05 were considered significant. All
P values were based on two-sided tests.
Results
1. Respondent characteristics
There were 27 respondents out of the 47 physicians (57%)
included in this study. Among these respondents were 9
physicians out of 17 (53%) from Tokushima University
Hospital, and 18 physicians out of 30 (60%; P > 0.05) from
other medical institutions. The response rate was 79% (15
out of 19) in physicians who actually recruited patients
(successful physician recruiters) compared to 43% (12 out
of 28; P = 0.014) in physicians unable to recruit patients
(unsuccessful physician recruiters) in the multicenter
trial of antihypertensive drugs.
2. Physicians' past experience of participation and patient 
enrollment in multicenter clinical trials
As for the relationship between past experience of partic-
ipation and patient enrollment in multicenter clinical tri-
als, and patient enrollment in the recent clinical trial,
there were more successful physician recruiters (73%)
than unsuccessful physician recruiters (42%) who indi-
cated having participated and enrolled patients in previ-
ous multicenter clinical trials (Table 1); however, the
difference in the number of doctors was not significant.
From the viewpoint of institutions, 45% of the physi-
cians from Tokushima University Hospital and 28% of the
physicians from other medical institutions stated that
they had participated and enrolled patients in previous
multicenter clinical trials (data not shown).
3. Reasons for participating as investigators in the recent 
clinical trial
We next examined and analyzed the reasons of physicians
in agreeing to participate in the recent clinical trial. ManyYanagawa et al. International Archives of Medicine 2010, 3:7
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successful physician recruiters considered the presence of
a support system with CRC as the reason for participa-
tion (80%), whereas a significantly smaller number of
unsuccessful physician recruiters considered such reason
(42%; P = 0.040) (Table 2). In terms of other reasons for
participation, no significant difference was found
between successful physician recruiters and unsuccessful
physician recruiters.
A smaller number of physicians from Tokushima Uni-
versity Hospital than from other medical institutions
(33% vs 94%; P = 0.001) considered agreement with the
aims of the study as the main reason for participating.
Instead, the main reason of physicians from Tokushima
University Hospital participating in the study was the
decision by the hospital to take part in the study (66%).
No significant difference in other views was observed
between the institutions (data not shown).
4. Views of physicians on the recent clinical trial after 
participation
The real views of physicians on the recent clinical trial
were also evaluated. Many unsuccessful physician
recruiters experienced difficulty in obtaining informed
consent (67%), whereas a significantly smaller number of
successful physician recruiters did (20%; P = 0.014) (Table
3). No significant difference in other views was observed
between successful physician recruiters and unsuccessful
physician recruiters.
The main view of the participating physicians from
Tokushima University Hospital regarding the trial was
that it involved cumbersome procedures (66%), while that
of the physicians from other medical institutions was
their inability to find possible participants (83%). No sig-
nificant difference in views was observed between insti-
tutions (data not shown).
5. Difficulties experienced by unsuccessful physician 
recruiters in patient enrollment in the recent clinical trial
Selected answers to the questions are shown in Table 4.
The difficulties experienced by physicians in patient
enrollment were as follows: inability to find possible par-
ticipants (100%), difficulty in obtaining informed consent
(58%), cumbersome procedures (58%), difficulty in long-
term follow up (33%), and insufficient tools for the proper
Table 1: Physicians' past experience of participation and patient enrollment in multicenter clinical trials, depending on 
capability of recruitment in the recent clinical trial
Past experience Successful physician recruiters (n = 15) Unsuccessful physician recruiters (n = 12)
Participation (+)
Enrollment (+) 11 (73%) 5 (42%)
Enrollment (-) 0 2 (16%)
Participation (-) 4 (27%) 5 (42%)
Participation (+) indicates those who have past experience of participation in multicenter clinical trials.
Participation (-) indicates those who have no past experience of participation in multicenter clinical trials.
Enrollment (+) indicates those who have past experience of patient enrollment in multicenter clinical trials.
Enrollment (-) indicates those who have no past experience of patient enrollment in multicenter clinical trials.
Table 2: Reasons for participating as investigators in the recent clinical trial, depending on capability of recruitment
Reasons for participating as 
investigators
Successful physician recruiters (n = 15) Unsuccessful physician recruiters (n = 12)
Agree Neutral Disagree Agree Neutral Disagree
Agreement with the study aims 12 (80%) 3 (20%) 0 8 (67%) 3 (25%) 1 (8%)
Simplicity of protocol 7 (47%) 6 (40%) 2 (13%) 5 (42%) 5 (42%) 2 (16%)
Interest in agents compared in the study 6 (40%) 7 (47%) 2 (13%) 4 (33%) 5 (42%) 3 (25%)
Expectation of high probability of patient 
enrollment
5 (33%) 8 (54%) 2 (13%) 1 (8%) 7 (59%) 4 (33%)
Presence of support system 12 (80%)* 2 (13%) 1 (7%) 5 (42%) 3 (25%) 4 (33%)
Decision of medical institution to which 
physicians belong
8 (53%) 1 87%) 6 (40%) 4 (34%) 6 (50%) 2 (16%)
*: Significantly different (P = 0.040) from the value for unsuccessful physician recruitersYanagawa et al. International Archives of Medicine 2010, 3:7
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explanation of the trial and for obtaining informed con-
sent (8%). No physician considered the following points
as difficulties: negative view on the clinical trial itself,
anxiety in the consultation system when some questions
arise, or unsatisfactory financial benefits.
6. Expectation regarding the support system provided by 
CRC and satisfaction from CRC participating in the recent 
clinical trial
Regarding the need for a support system as provided by
CRC, 100% and 75% of the successful physician recruiters
and unsuccessful physician recruiters, respectively, con-
sidered the support given by CRC as necessary for them
to participate in clinical trials as their actual view. Among
the 15 successful physician recruiters, 13 (87%) expressed
satisfaction with the support provided by CRC in the
recent clinical trial (data not shown).
Discussion
Many clinical trials in the general practice setting have
been conducted in efforts to provide evidence for the
effectiveness and safety of different agents in patients
with common diseases under various conditions. Most
patients with common diseases are managed by not only
hospital specialists, but also GPs. The participation of
GPs and patient recruitment are, therefore, important
issues to be properly addressed when carrying out clinical
trials. Once GPs agree to participate in a clinical trial,
establishing a good relationship with them and the facili-
tation staff is crucial to the success of the trial. In the clin-
ical trial described here, the Clinical Trial Center for
Developmental Therapeutics of Tokushima University
Hospital played a key role in facilitating communication
with physicians from the participating medical institu-
tions as well as in promoting patient enrollment in the
Table 3: View of physicians on the recent clinical trial after participation, depending on capability of recruitment
View of physicians on the recent clinical 
trial after participation
Successful physician recruiters (n = 15) Unsuccessful physician recruiters (n = 12)
Agree Neutral Disagree Agree Neutral Disagree
Inability to find possible participants 10 (66%) 4 (27%) 1 (7%) 10 (83%) 2 (17%) 0
Difficulty in obtaining informed consent 3 (20%) 7 (47%) 5 (33%) 8 (67%)* 3 (25%) 1 (8%)
Insufficient tools for explanation and so on 0 6 (40%) 9 (60%) 1 (8%) 5 (42%) 6 (50%)
Cumbersome procedures 7 (47%) 5 (33%) 3 (20%) 6 (50%) 4 (33%) 2 (17%)
Improvement needed in registration 6 (40%) 7 (47%) 2 (13%) 4 (34%) 4 (33%) 4 (33%)
Difficulty in long-term follow up 1 (7%) 5 (33%) 9 (60%) 4 (33%) 5 (42%) 3 (25%)
Improvement needed in follow-up system 1 (7%) 9 (60%) 5 (33%) 1 (8%) 5 (42%) 6 (50%)
Appropriate consultation system 6 (40%) 8 (53%) 1 (7%) 3 (25%) 4 (33%) 5 (42%)
Appropriate financial benefits 5 (33%) 9 (60%) 1 (7%) 4 (33%) 5 (42%) 3 (25%)
*: Significantly different (P = 0.014) from the value for successful physician recruiters
Table 4: Areas of difficulty experienced by unsuccessful physician recruiters in terms of patient enrollment in the recent 
clinical trial
Areas of difficulty Unsuccessful physician recruiters (n = 12)
Agree Neutral Disagree
Negative view on the clinical trial itself 0 4 (33%) 8 (67%)
Inability to find possible participants 12 (100%) 0 0
Difficulty in obtaining informed consent 7 (58%) 3 (25%) 2 (17%)
Insufficient tools for explanation and so on 1 (8%) 6 (50%) 5 (42%)
Cumbersome procedures 7 (58%) 4 (33%) 1 (8%)
Difficulty in long-term follow up 4 (33%) 6 (50%) 2 (17%)
Anxiety in consultation system when some questions arise 0 5 (42%) 7 (58%)
Unsatisfactory financial benefits 0 4 (33%) 8 (67%)Yanagawa et al. International Archives of Medicine 2010, 3:7
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regional area. Such facilitation included regular commu-
nication by sending letters, holding seminars to gain
knowledge from specialists, and providing tools for vari-
ous settings, such as those for obtaining informed con-
sent. Because of this facilitation, 19 (40%) physicians from
13 (68%) medical institutions were able to recruit patients
in the recent clinical trial; however, the rest were unable
to accomplish patient enrollment. In this regard, the
objective of our study was to analyze the views and atti-
tudes of physicians unable to recruit patients while par-
ticipating in the trial, and to provide information useful
for developing an effective strategy for improving such
inability to recruit patients through the provision of sup-
port staff, including CRC, in future clinical studies.
In the present investigation, a significantly higher num-
ber of successful physician recruiters than unsuccessful
physician recruiters considered the support system with
CRC as the reason for their participation in the trial
(Table 2). Moreover, regarding the need for support pro-
vided by CRC, 100% and 75% of the recruiting-capable
and recruiting-incapable physicians, respectively, consid-
ered such support necessary for them to participate in
clinical trials. In the present study, the influence of the
experience of participating and enrolling patients in pre-
vious multicenter clinical tri a l s  o n  t h e  c a p a b i l i t y  o f
patient recruitment was not significant, at least partly
because of the potential lack of power to detect differ-
ences. Nevertheless, successful physician recruiters may
have more past experience in participating and enrolling
patients in previous clinical trials, and they are more
aware than unsuccessful physician recruiters of the work-
load of clinical trials, as well as the contributions of CRC
to lessen workload and to ensure the quality of the trials
[6]. The possible contribution of the CRC to recruitment
outcome should be examined precisely in future studies.
A systematic review by Ross et al. [7] of 78 papers
reporting barriers to the recruitment of clinicians to ran-
domized controlled trials revealed that clinician barriers
included the following: time constraints, lack of staff and
training, anxieties about the impact on the doctor-patient
relationship, concern for patients, loss of professional
autonomy, difficulty with the consent procedure, lack of
rewards and recognition, and insufficient interesting
questions. In their review, the term "clinician" included all
types of clinical staff, and the differing levels of participa-
tion--agreeing to participate when invited, recruiting eli-
gible patients, and following the trial protocol--were
considered together. On the other hand, only difficulties
in patient enrollment were considered in the present
study. After participation, a larger number of unsuccess-
ful physician recruiters than successful physician recruit-
ers (20%; P = 0.014) experienced difficulty in obtaining
informed consent (67%) (Table 3); inability to find possi-
ble participants, difficulty in obtaining informed consent,
cumbersome procedures, and difficulty in long-term fol-
low up were pointed out as the main areas of difficulty for
unsuccessful physician recruiters in terms of patient
enrollment in the recent clinical trial. Since less than half
of the respondents had past experience in patient enroll-
ment, unsuccessful physician recruiters were ill-prepared
for practical procedures, such as participant estimation
and obtaining informed consent in the clinical trial. Diffi-
culty in obtaining informed consent was also mentioned
by Taylor et al. [3] as one of the reasons why surgical prin-
cipal investigators do not enter all eligible patients in a
large multicenter trial in surgical procedures against
breast cancer.
It has been reported that clinicians participating in
clinical trials have low recognition concerning their role
in research due to inadequate research experience or
training [8,9]. Japanese doctors in general still have little
undergraduate or postgraduate opportunities for training
in different the methodologies or regulatory issues of
clinical trials. In 2004, to construct an infrastructure for
implementing a clinical trial in a regional area of Tokush-
ima, Japan, Tokushima University Hospital organized the
Tokushima Network for Clinical Trials (TNCT), which is
composed of regional medical institutions, in collabora-
tion with the Tokushima Medical Association. Several
seminars with clinical trial specialists as guest speakers
have been given as TNCT seminars annually since 2004.
In addition, monthly training seminars conducted by the
Clinical Trial Center for Developmental Therapeutics of
Tokushima University Hospital, which had been provided
for doctors in Tokushima University Hospital from 2001,
were made open to TNCT members in 2007.
As for the support system for clinical trials, in a mail
survey of 221 oncologists, Somkin et al. [10] reported that
the best combination of factors independently predicting
enrollment related to organizational support for trials are
the subspecialty of the oncologist and limitations of trial
eligibility requirements, and that to increase trial partici-
pation, there is a critical need for an infrastructure to
support trials, particularly additional support staff and
research nurses. Since resources for clinical trials are lim-
ited, investigators who will conduct clinical trials must be
aware of research infrastructure costs in future studies.
The present study is descriptive, with the potential of
partly or merely justifying the inability of physicians to
enroll patients in a clinical trial rather than explaining its
causes. In addition, there was a significantly lower
response rate among unsuccessful physician recruiters
which may lead to significant bias. Nevertheless, the pres-
ent study suggests that further clarification of the impact
of CRC on clinical trials is necessary and future works
including seminars should focus on the areas revealed by
this study to be difficult for physicians in terms of patient
recruitment in clinical trials. Because of the various studyYanagawa et al. International Archives of Medicine 2010, 3:7
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limitations, further study is warranted to determine the
generalizability of the present findings to other Japanese
areas and to international settings.
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